Namwiwat Medical PCLBKK:NAM -1.73%40 Days Payable is 72.81 as of Mar. 2026, which is 109% above its 10-year median of 34.88. GuruFocus rates BKK:NAM with a GF Score™ of 40/100 and a GF Value™ of ฿6.04 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Namwiwat Medical PCL ranks worse than 51.82% on this metric.
The historical rank and industry rank for Namwiwat Medical PCL's Days Payable or its related term are showing as below:
BKK:NAM'
s Days Payable Range Over the Past 10 Years
Min: 25.39 Med: 34.88 Max: 66.45
Current: 66.45
During the past 6 years, Namwiwat Medical PCL's highest Days Payable was 66.45. The lowest was 25.39. And the median was 34.88.
BKK:NAM's Days Payable is ranked worse than 51.82% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs BKK:NAM: 66.45
Namwiwat Medical PCL's Days Payable
increased
from Mar. 2025 (40.77) to Mar. 2026 (72.81).
It may suggest that Namwiwat Medical PCLdelayed paying its suppliers.
Namwiwat Medical PCL Days Payable Related Terms
Namwiwat Medical PCL Days Payable Historical Data
* Premium members only.
The historical data trend for Namwiwat Medical PCL's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Namwiwat Medical PCL's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Namwiwat Medical PCL Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Namwiwat Medical PCL's Days Payable distribution charts can be found below:
* The bar in red indicates where Namwiwat Medical PCL's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Namwiwat Medical PCL's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Namwiwat Medical PCL (BKK:NAM) has a Days Payable of 72.81 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Namwiwat Medical PCL and its competitors. This is 109% above median its historical median of 34.88. Over the past decade, Namwiwat Medical PCL's Days Payable has ranged from 25.39 to 66.45. According to the industry distribution chart, Namwiwat Medical PCL ranks #412 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 51.8%.
Is Namwiwat Medical PCL's Days Payable too high?
Namwiwat Medical PCL's current Days Payable of 72.81 is 109% above median its 10-year median of 34.88. Over the past 10 years, this metric has ranged from a low of 25.39 to a high of 66.45. The Medical Devices & Instruments industry median Days Payable is 68.07. Namwiwat Medical PCL's value of 72.81 is 7% above this industry median. Based on the distribution chart, Namwiwat Medical PCL ranks #412 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Namwiwat Medical PCL has a GF Score™ of 40/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Namwiwat Medical PCL's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Namwiwat Medical PCL ranks #412 out of 795 companies for Days Payable. This places Namwiwat Medical PCL in the lower half of its industry. The industry median Days Payable is 68.07. Namwiwat Medical PCL's value of 72.81 is 7% above this benchmark. Historically, Namwiwat Medical PCL's own Days Payable has ranged from 25.39 to 66.45 over the past decade. While the company's 10-year median is 34.88 vs. the industry median of 68.07, Namwiwat Medical PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Namwiwat Medical PCL's current Days Payable of 72.81 is 7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Namwiwat Medical PCL and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Namwiwat Medical PCL's current Days Payable is 72.81, which is 109% above median its own 10-year median of 34.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Namwiwat Medical PCL stock overvalued right now?
Based on GuruFocus' analysis, Namwiwat Medical PCL (BKK:NAM) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿6.04, compared to a current price of ฿3.40 — trading 43.7% below its estimated fair value. The current Days Payable is 72.81, which is 109% above median its 10-year median of 34.88 and 7% above the Medical Devices & Instruments industry median of 68.07. Namwiwat Medical PCL's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Namwiwat Medical PCL (BKK:NAM), the current Days Payable is 72.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Namwiwat Medical PCL (BKK:NAM) Overvalued in 2026?
Based on GuruFocus' analysis, Namwiwat Medical PCL stock appears to be undervalued.
The current stock price of ฿3.40 is trading 43.7% below its estimated GF Value™ of ฿6.04.
GuruFocus considers Namwiwat Medical PCL to be Significantly Undervalued.
Key valuation signals for BKK:NAM:
Days Payable: 72.81 (109% above median its 10-year median of 34.88)
GF Value™: ฿6.04 vs. price of ฿3.40 (43.7% below fair value)
Industry Position: 7% above the Medical Devices & Instruments median (#412 of 795)
No single metric tells the full story. See the BKK:NAM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Namwiwat Medical Corp PCL operates a manufacturing business, importing and distributing Medical tools and equipment for cleaning and disinfecting medical equipment in hospitals and nursing homes in accordance with public health standards. The Group has a total of three reporting segments as follows: Medical equipment manufacturing and distribution segment; Medical supplies manufacturing and distribution segment; CSSD disinfection Medical equipment maintenance services segment, and waste services segment. The Group operates its business in one geography, only in Thailand.
40GF Score
Get the complete analysis for BKK:NAM
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NAM has been successfully added to your 
